Literature DB >> 18288389

A ginseng saponin metabolite suppresses tumor necrosis factor-alpha-promoted metastasis by suppressing nuclear factor-kappaB signaling in murine colon cancer cells.

Min-Kyung Choo1, Hiroaki Sakurai, Dong-Hyun Kim, Ikuo Saiki.   

Abstract

SC-514, an inhibitor of IkappaB kinase beta (IKKbeta), blocked the TNF-alpha-induced activation of nuclear factor-kappaB (NF-kappaB) as well as the TNF-alpha-promoted metastasis of murine colon adenocarcinoma cells. We investigated the effect of 20-O-beta-D-glucopyranosyl-20(S)-protopanaxadiol (M1), a main intestinal bacterial metabolite of ginseng, on the NF-kappaB-dependent metastasis. M1 was effective in suppressing the TNF-alpha-induced activation of NF-kappaB, expression of matrix metalloprotease-9 (MMP-9), migration and invasion. The TNF-alpha-evoked increase in lung and liver metastasis of colon carcinoma was also abrogated by treatment with M1 in vitro. These results suggest that ginseng has potential to suppress inflammation-related metastasis by downregulating the NF-kappaB signaling pathway.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18288389

Source DB:  PubMed          Journal:  Oncol Rep        ISSN: 1021-335X            Impact factor:   3.906


  38 in total

1.  Effect of expressions of tumor necrosis factor α and interleukin 1B on peritoneal metastasis of gastric cancer.

Authors:  Lin Guo; Jin-Lei Ou; Tong Zhang; Liang Ma; Long-Fei Qu
Journal:  Tumour Biol       Date:  2015-06-12

2.  Antitumor and antimetastatic effects of licochalcone A in mouse models.

Authors:  Jin-Kyung Kim; Eun Kyung Shin; Jun Hong Park; Yoon Hee Kim; Jung Han Yoon Park
Journal:  J Mol Med (Berl)       Date:  2010-04-11       Impact factor: 4.599

3.  Ginsenoside metabolite compound K enhances the efficacy of cisplatin in lung cancer cells.

Authors:  Yang Li; Tong Zhou; Chengyuan Ma; Weiwei Song; Jian Zhang; Zhenxiang Yu
Journal:  J Thorac Dis       Date:  2015-03       Impact factor: 2.895

Review 4.  Bioactivity enhancement of herbal supplements by intestinal microbiota focusing on ginsenosides.

Authors:  Huai-You Wang; Lian-Wen Qi; Chong-Zhi Wang; Ping Li
Journal:  Am J Chin Med       Date:  2011       Impact factor: 4.667

5.  Inhibitors of NF-kappaB reverse cellular invasion and target gene upregulation in an experimental model of aggressive oral squamous cell carcinoma.

Authors:  Jeff Johnson; Zonggao Shi; Yueying Liu; M Sharon Stack
Journal:  Oral Oncol       Date:  2014-02-28       Impact factor: 5.337

Review 6.  The NF-kappaB activation pathways, emerging molecular targets for cancer prevention and therapy.

Authors:  Yong Lin; Lang Bai; Wenjie Chen; Shanling Xu
Journal:  Expert Opin Ther Targets       Date:  2010-01       Impact factor: 6.902

7.  Joint-protective effects of compound K, a major ginsenoside metabolite, in rheumatoid arthritis: in vitro evidence.

Authors:  Yong Seok Choi; Eun Ha Kang; Eun Young Lee; Hyun Sik Gong; Heun Soo Kang; Kichul Shin; Eun Bong Lee; Yeong Wook Song; Yun Jong Lee
Journal:  Rheumatol Int       Date:  2013-01-31       Impact factor: 2.631

8.  Identification of a potent natural triterpenoid inhibitor of proteosome chymotrypsin-like activity and NF-kappaB with antimyeloma activity in vitro and in vivo.

Authors:  Rodger E Tiedemann; Jessica Schmidt; Jonathan J Keats; Chang-Xin Shi; Yuan Xiao Zhu; Stephen E Palmer; Xinliang Mao; Aaron D Schimmer; A Keith Stewart
Journal:  Blood       Date:  2008-12-18       Impact factor: 22.113

9.  Clinical significance of serum interleukin-29, interleukin-32, and tumor necrosis factor alpha levels in patients with gastric cancer.

Authors:  Kayhan Erturk; Didem Tastekin; Murat Serilmez; Elif Bilgin; Hamza Ugur Bozbey; Sezai Vatansever
Journal:  Tumour Biol       Date:  2015-07-29

10.  Compound K, a metabolite of ginseng saponin, induces apoptosis via caspase-8-dependent pathway in HL-60 human leukemia cells.

Authors:  Sung-Hee Cho; Kyung-Sook Chung; Jung-Hye Choi; Dong-Hyun Kim; Kyung-Tae Lee
Journal:  BMC Cancer       Date:  2009-12-18       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.